Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease

6 giugno 2026 aggiornato da: Fatih Söke, Saglik Bilimleri Universitesi

Comparison of Motor-Motor and Cognitive-Motor Dual-Task Training in Patients With Parkinson's Disease

The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are:

- Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease in terms of their effects on motor symptoms, balance, gait, functional mobility, activities of daily living, dual-task activities, cognitive functions, and balance confidence.

Researchers will compare single-task training, motor-motor dual task training and cogvitive-motor dual task training.

Participants will:

  • Receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks.
  • Participate in assessments at the study clinic before and after exercise training.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Stimato)

39

Fase

  • Non applicabile

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Having been diagnosed with Parkinson's disease by a neurologist according to the UK Brain Bank criteria.
  • Being in stages 1-3 according to the Hoehn-Yahr Scale.

Exclusion Criteria:

  • Presence of a neurological disease other than Parkinson's disease
  • Cognitive impairment (Standardized Mini Mental Test score less than 24)
  • Having undergone deep brain stimulation surgery
  • Having a visual, auditory, or perceptual problem
  • Having any orthopedic, rheumatological, or other condition that may affect walking and balance.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Single Task Training
Single task balance and walking training
Altro: Single Task Exercise Training
Single task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises with a 5-minute rest in between, and then a 5-minute cool-down period.
Sperimentale: Motor-Motor Dual Task Training
Motor-motor dual task balance and walking training
Altro: Motor-Motor Dual Task Exercise Training
Motor-motor dual task balance and walking exercises. Motor-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with upper extremity motor tasks with a 5-minute rest in between, and then a 5-minute cool-down period.
Sperimentale: Cognitive-Motor Dual Task Training
Cognitive-motor dual task balance and walking training
Altro: Cognitive-Motor Dual Task Exercise Training
Cognitive-motor dual task balance and walking exercises. Cognitive-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with cognitive tasks with a 5-minute rest in between, and then a 5-minute cool-down period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 3
Lasso di tempo: From enrollment to the end of training at 6 weeks
UPDRS is a reliable and valid scale that assesses cognitive skills, mood, daily living activities, motor skills, motor fluctuations, dyskinesias and autonomic dysfunction and is widely used in clinical studies and research in Parkinson's disease. The motor symptoms section, which is the third section of this scale, will be used.
From enrollment to the end of training at 6 weeks
Hoehn & Yahr Scale
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
It is a staging system that provides information quickly in determining the severity and symptoms of Parkinson's disease.
From enrollment to the end of treatment at 6 weeks
Single-Leg Stance Test
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
This is a test method used to assess static balance. The patient's preferred foot is raised without touching the supporting leg, and initially, the eyes are open. The eyes are fixed towards the head, and the patient is expected to maintain their balance for 60 seconds. The time the participant maintains their balance is recorded.
From enrollment to the end of treatment at 6 weeks
Functional Reach Test
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
This test is designed to assess dynamic balance. In the test, the participant is positioned sideways next to a wall, with their torso upright, the shoulder on the wall flexed to 90°, and the elbow fully extended. The participant is then asked to make a fist with the same arm, and the position of the third metacarpal head is marked on the wall. The participant reaches forward with their knees fully extended; the position of the third metacarpal head is marked again, and the participant returns to the starting position. The difference between the two marks is measured with a tape measure.
From enrollment to the end of treatment at 6 weeks
10 Meter Walking Test
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
Participants are asked to walk at normal walking speed for a distance of 10 meters and the time is recorded.
From enrollment to the end of treatment at 6 weeks
Motor-Motor Dual Task Cost of Walking
Lasso di tempo: From enrollment to the end of treatment at 6 weeks

To assess the motor-motor dual-task cost of walking, patients will perform the 10-meter walk test once as a single task and once while holding an empty plate on a tray in their hands. The dual-task cost will be calculated as a percentage using the following formula:

[(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]
From enrollment to the end of treatment at 6 weeks
Cognitive-Motor Dual Task Cost of Walking
Lasso di tempo: From enrollment to the end of treatment at 6 weeks

To assess cognitive-motor dual-task cost of walking, patients will perform the 10-Meter Walk Test once as a single task and once as a dual-task test, counting backwards in increments of 7 from a three-digit number greater than 300. Dual-task cost will be calculated as a percentage using the following formula:

[(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]
From enrollment to the end of treatment at 6 weeks
Timed Up and Go Test
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
This test is used to assess functional mobility levels. The test involves using a standard chair with the individual's knees flexed at 90° and their backrest against it. The individual is asked to stand up from the chair, walk 3 meters, turn around, and then walk back to the chair and sit down. The test begins with the command "walk," and the test duration is measured with a stopwatch and recorded in seconds.
From enrollment to the end of treatment at 6 weeks
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 2
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
It consists of thirteen items. The assessment is based on anamnesis information regarding how the patient functions in various activities. The presence of sensory complaints that may be related to tremor and parkinsonism is also included in this section as they can affect daily living activities. Each item is evaluated using a scoring system between '0' and '4'.
From enrollment to the end of treatment at 6 weeks
Dual Task Questionnaire
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
This test is used to assess the challenges encountered in daily tasks involving dual work. It consists of 10 questions and is administered via face-to-face interview. Each question is scored between 0 and 4. A score of "4" indicates frequent challenges, while a score of "0" indicates no challenges.
From enrollment to the end of treatment at 6 weeks
Trail Making Test
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
It is used to assess executive functions and attention. The test consists of two parts, A and B. In part A, the individual is asked to combine numbers from 1 to 25, and the completion time is recorded. In part B, the individual completes a sequence where each number corresponds to a letter, and the completion time is recorded.
From enrollment to the end of treatment at 6 weeks
Activity-Specific Balance Confidence Scale
Lasso di tempo: From enrollment to the end of treatment at 6 weeks
This is a commonly used scale for assessing balance confidence. The scale evaluates whether individuals believe they can perform daily living activities without losing their balance or becoming unsteady. It consists of sixteen items. Each item is scored between a minimum of "0" (unconfident) and a maximum of "100" (completely confident). The base score is calculated by dividing the total score by 16. Higher values indicate that the person feels good about their balance, while lower values are associated with an increased risk of falls.
From enrollment to the end of treatment at 6 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Saglik Bilimleri Universitesi

Collaboratori

Eskisehir Osmangazi University
Anadolu University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 giugno 2026

Completamento primario (Stimato)

1 settembre 2026

Completamento dello studio (Stimato)

15 settembre 2026

Date di iscrizione allo studio

Primo inviato

6 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

6 giugno 2026

Primo Inserito (Effettivo)

11 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

11 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

6 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 2026-152

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Malattia di Parkinson (MdP)

Prove cliniche su Single Task Exercise Training

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Portugal

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

Sottoscrivi